aluminum oxide has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, L; Fang, Y; Lai, W; Li, K; Lin, B; Liu, H; Liu, X; Tian, L; Xi, Z; Yang, H; Zhang, W | 1 |
| Armstrong, V; Arnold, I; Karyakina, NA; Krewski, D; Momoli, F; Nordheim, E; Shilnikova, NS; Willhite, CC; Yenugadhati, N | 1 |
2 other study(ies) available for aluminum oxide and Encephalopathy, Toxic
| Article | Year |
|---|---|
Neurotoxicity of aluminum oxide nanoparticles and their mechanistic role in dopaminergic neuron injury involving p53-related pathways.
Topics: Aluminum Oxide; Animals; Apoptosis; Brain; Cell Survival; Dopaminergic Neurons; Male; Nanoparticles; Neurotoxicity Syndromes; Oxidative Stress; PC12 Cells; Rats; Rats, Wistar; Signal Transduction; Tumor Suppressor Protein p53 | 2020 |
The REACH registration process: A case study of metallic aluminium, aluminium oxide and aluminium hydroxide.
Topics: Aluminum; Aluminum Hydroxide; Aluminum Oxide; Animals; Europe; European Union; Humans; Nervous System; Neurotoxicity Syndromes; Risk Assessment; Toxicity Tests; Toxicokinetics | 2021 |